Search Results - "Scherer, Noreen"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Safety, pharmacokinetics, and pharmacodynamics of nomlabofusp (CTI‐1601) in Friedreich's ataxia by Clayton, Russell, Galas, Teresa, Scherer, Noreen, Farmer, Jennifer, Ruiz, Nancy, Hamdani, Mohamed, Schecter, Devin, Bettoun, David

    “…Objective Current treatments for Friedreich's ataxia, a neurodegenerative disorder characterized by decreased intramitochondrial frataxin, do not address low…”
    Get full text
    Journal Article
  2. 2

    A Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder by Biederman, Joseph, Melmed, Raun D, Patel, Anil, McBurnett, Keith, Konow, Jennifer, Lyne, Andrew, Scherer, Noreen, SPD503 Study Group

    Published in Pediatrics (Evanston) (01-01-2008)
    “…With this study we assessed the efficacy and safety of an extended-release formulation of guanfacine compared with placebo for the treatment of children and…”
    Get full text
    Journal Article
  3. 3

    N-Phenyl-2-pyridinecarbothioamides as gastric mucosal protectants by Kinney, William A, Lee, Nancy E, Blank, Robert M, Demerson, Christopher A, Sarnella, Carol S, Scherer, Noreen T, Mir, G. Nabi, Borella, Luis E, DiJoseph, John F, Wells, Cheryl

    Published in Journal of medicinal chemistry (01-01-1990)
    “…A series of substituted 2-pyridinecarbothioamides was synthesized and evaluated for gastric mucosal protectant activity in the rat. Out of this investigation…”
    Get full text
    Journal Article